Aims & Scope

Genes & Diseases is an international journal for molecular and translational medicine.

The journal primarily focuses on publishing investigations on the molecular bases and experimental therapeutics of human diseases.

Publication formats include full length research article, review article, short communication, correspondence, perspectives, commentary, views on news, and research watch.

Genes & Diseases publishes rigorously peer-reviewed and high quality original articles and authoritative reviews that focus on the molecular bases of human diseases.

Emphasis will be placed on hypothesis-driven, mechanistic studies relevant to pathogenesis and/or experimental therapeutics of human diseases.

The journal has worldwide authorship, and a broad scope in basic and translational biomedical research of molecular biology, molecular genetics, and cell biology, including but not limited to cell proliferation and apoptosis, signal transduction, stem cell biology, developmental biology, gene regulation and epigenetics, cancer biology, immunity and infection, neuroscience, disease-specific animal models, gene and cell-based therapies, and regenerative medicine.

View Aims & Scope

Metrics & Ranking

Impact Factor

Year Value
2025 9.4
2024 6.90

Journal Rank

Year Value
2024 2044

Journal Citation Indicator

Year Value
2024 3080

SJR (SCImago Journal Rank)

Year Value
2024 1.646

Quartile

Year Value
2024 Q1

h-index

Year Value
2024 63

Impact Factor Trend


Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.


Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology and Medicine, designed to support cutting-edge academic discovery.


Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.


Policy Links

This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.


Advertisement

Quick Facts

Current Factor
9.4
First Published: 2025

SJR (SCImago Journal Rank)

SJR
1.646
First Published: 2024

Quartile

Current Quartile
Q1
First Published: 2024

Similar Journals

Top Journals in Related Fields

Need Help?